Compare APM & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APM | GXAI |
|---|---|---|
| Founded | 2010 | 2021 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0M | 8.9M |
| IPO Year | 2018 | 2023 |
| Metric | APM | GXAI |
|---|---|---|
| Price | $0.83 | $1.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 69.3K | ★ 15.6M |
| Earning Date | 04-29-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $694,278.00 |
| Revenue This Year | N/A | $42,959.35 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 23205.74 |
| 52 Week Low | $0.69 | $1.00 |
| 52 Week High | $4.47 | $2.96 |
| Indicator | APM | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 34.24 | 61.38 |
| Support Level | $0.80 | $1.20 |
| Resistance Level | $1.02 | $2.63 |
| Average True Range (ATR) | 0.08 | 0.24 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 11.50 | 39.42 |
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.